IGC PHARMA, INC. (IGC) Capital expenditures 2016–2025
IGC PHARMA, INC. (IGC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$112,000FY2025 · since FY2016: $122,185 → $112,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $112,000 | -18.8% |
| FY2024 | $138,000 | -55.5% |
| FY2023 | $310,000 | +31.4% |
| FY2022 | $236,000 | -83.9% |
| FY2021 | $1.5M | -66.5% |
| FY2020 | $4.4M | +29160.0% |
| FY2019 | $15,000 | -89.0% |
| FY2018 | $136,000 | -6.6% |
| FY2017 | $145,677 | +19.2% |
| FY2016 | $122,185 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice